Bobby is a senior consultant in Monitor Deloitte’s Health Care & Life Sciences Strategy practice, with experience in the life sciences industry and a focus on biotech companies. He has worked extensively with biotech and pharma clients to develop their commercial and market access strategy across a range of therapy areas including oncology, immunology and kidney disease.